In the past, insulin used by diabetics was obtained from pig pancreases. Now that we know the DNA sequence of the gene responsible, we can insert this gene into a plasmid (technically called a construct) and transform some e.coli (usually strain HB101). This allows large quantities to be produced with a much reduced cost. The gene sequence is basically the same and the resulting insulin is basically the same from both sources.